Physician profile
Serena Cobb
NPI 1396286431
$6,916.39
in general payments reported to CMS, 2019-2025
46 companies · $2,552 in 2025
The $2,552 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $566 · 2023: $1,494 · 2024: $2,305 · 2025: $2,552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,350.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $859.56 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $699.60 | 2022-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $693.49 | 2023-2025 | |
| Lilly USA, LLC | $572.73 | 2022-2025 | Mounjaro, Zepbound, Trulicity |
| Novo Nordisk INC | $521.59 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $377.11 | 2022-2025 | Repatha, Repatha, Krystexxa |
| Glaxosmithkline, LLC. | $371.36 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $255.43 | 2023-2025 | Jardiance |
| Astellas Pharma US INC | $244.98 | 2023-2025 | Veozah, Myrbetriq |
| Exact Sciences Corporation | $202.93 | 2023-2025 | Cologuard Collection Kit |
| Vanda Pharmaceuticals INC. | $202.02 | 2025 | Fanapt, Hetlioz |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $154.88 | 2025 | Caplyta |
| Xeris Pharmaceuticals, INC. | $133.31 | 2023-2025 | Keveyis, Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $124.40 | 2022-2025 | |
| Antares Pharma, INC. | $123.38 | 2022 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $111.45 | 2024-2025 | Korlym |
| Sumitomo Pharma America, INC. | $109.85 | 2024-2025 | Gemtesa |
| Medtronic, INC. | $108.65 | 2022-2025 | Intellis Adaptivestim |
| Boston Scientific Corporation | $90.30 | 2024-2025 | Watchman Flx, Wavewriter Alpha Prime 16, Watchman Access System |
| Mylan Specialty L.P. | $88.25 | 2022-2024 | Yupelri |
| Edwards Lifesciences Corporation | $70.62 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $65.69 | 2023-2024 | Freestyle Libre |
| Esperion Therapeutics, INC. | $62.15 | 2024-2025 | Nexletol |
| Otsuka America Pharmaceutical, INC. | $56.84 | 2024 | Rexulti |
| Seqirus USA INC | $52.94 | 2025 | Flucelvax, Fluad |
| Axsome Therapeutics, INC. | $52.01 | 2024-2025 | Auvelity |
| Sanofi-Aventis U.S. LLC | $49.10 | 2025 | |
| Abiomed | $40.33 | 2025 | |
| Biocryst US Sales Co., LLC | $33.34 | 2024 | Orladeyo |
| Mayne Pharma Commercial LLC | $30.11 | 2024 | |
| Janssen Pharmaceuticals, INC | $28.55 | 2022 | |
| Dexcom, INC. | $28.33 | 2025 | Dexcom G6 Transmitter |
| Alexion Pharmaceuticals, INC. | $26.46 | 2025 | Strensiq |
| Biohaven Pharmaceutical Holding Company LTD. | $26.31 | 2022 | |
| Daiichi Sankyo INC. | $26.22 | 2025 | Injectafer |
| Irhythm Technologies, INC. | $25.81 | 2024 | Zio Monitor, Zio Xt Patch |
| Kyowa Kirin, INC. | $25.44 | 2023 | Crysvita |
| Horizon Therapeutics Plc | $24.23 | 2023 | Krystexxa |
| Viatris Specialty LLC | $23.05 | 2025 | Yupelri |
| Inari Medical, INC. | $22.66 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Merck Sharp & Dohme LLC | $19.23 | 2025 | Capvaxive, Gardasil 9 |
| Agios Pharmaceuticals, INC. | $18.51 | 2024 | Pyrukynd |
| Cashflow Solutions, LLC | $16.50 | 2023 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Kowa Pharmaceuticals America, INC. | $16.32 | 2025 | Zoryve |
| Lundbeck LLC | $16.13 | 2024 | Rexulti |
| Inspire Medical Systems, INC. | $14.24 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Serena Cobb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.